Joanne Trinh

Dr. Joanne Trinh


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
CGCarolin Gabbert
Carolin Gabbert
LBLeonie Blöbaum
Leonie Blöbaum
TLTheresa Lüth
Theresa Lüth
IKInke R. König
Inke R. König
ACAmke Caliebe
Amke Caliebe
JTJoanne Trinh
Joanne Trinh
The objective of this study was to investigate the association between a Parkinson’s disease (PD)-specific polygenic score (PGS) and protective lifestyle factors on age at onset (AAO) in PD. We included data from 4367 patients with idiopathic PD, 159 patients with GBA1-PD, and 3090 healthy controls of European ancestry from AMP-PD, PPMI, and Fox Insight cohorts. The association between PGS and lifestyle factors on AAO was assessed with linear and Cox proportional hazards models. The PGS showed a negative association with AAO (β = − 1.07, p = 6 × 10–7) in patients with idiopathic PD. The use of one, two, or three of the protective lifestyle factors showed a reduction in the hazard ratio by 21% (p = 0.0001), 44% (p < 2 × 10–16), and 55% (p < 2 × 10–16), compared to no use. An additive effect of aspirin (β = 7.62, p = 9 × 10–7) and PGS (β = − 1.58, p = 0.0149) was found for AAO without an interaction (p = 0.9993) in the linear regressions, and similar effects were seen for tobacco. In contrast, no association between aspirin intake and AAO was found in GBA1-PD (p > 0.05). In our cohort, coffee, tobacco, aspirin, and PGS are independent predictors of PD AAO. Additionally, lifestyle factors seem to have a greater influence on AAO than common genetic risk variants with aspirin presenting the largest effect.

12 June 2025 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
TLTheresa Lüth
Theresa Lüth
ACAmke Caliebe
Amke Caliebe
CGCarolin Gabbert
Carolin Gabbert
SSSebastian Sendel
Sebastian Sendel
BLBjörn-Hergen Laabs
Björn-Hergen Laabs
JTJoanne Trinh
Joanne Trinh
Longitudinal investigations on the relationship between lifestyle exposures and motor severity are lacking. In this longitudinal study, we included patients with idiopathic Parkinson’s disease (iPD) (N = 5139) and LRRK2-related PD (N = 81) from PPMI-Online and Fox Insight. Motor aspects were followed for up to five years. We investigated the association between environmental exposure, lifestyle factors and motor aspect severity over time by applying linear mixed effects models. In LRRK2-PD, black tea consumption was associated with less severe motor aspects (β = −0.51, p = 0.028). In patients with iPD, pesticide exposure was associated with more severe motor aspects over time in PPMI-Online (β = 0.23, p = 3.56 × 10− 9). Lastly, caffeinated soda was associated with more severe motor aspects in patients with iPD from PPMI-Online (β = 0.15, p = 3.84 × 10−8) and Fox Insight (β = 0.09, p = 0.031). We suggest that pesticide exposure and lifestyle factors may affect motor severity in patients with LRRK2-PD and iPD, demonstrating the impact on patients even after disease onset.

17 May 2025 in Brain
Verified
Journal Article
Open access
JLJoshua Laß
Joshua Laß
MTMirja Thomsen
Mirja Thomsen
MBMax Borsche
Max Borsche
TLTheresa Lüth
Theresa Lüth
JPJulia C Prietzsche
Julia C Prietzsche
JTJoanne Trinh
Joanne Trinh
Deep intronic FGF14 repeat expansions have been identified as a frequent genetic cause of late-onset cerebellar ataxias, explaining ≤30% of patients. Interruptions between repeats have previously been identified to impact the penetrance in other repeat expansion disorders. Repeat interruptions within FGF14 have yet to be characterized in detail. We used long-range PCR, Sanger sequencing, repeat-primed PCR, Nanopore and PacBio sequencing to distinguish the repeat motifs, mosaicism and number of repeat interruptions present in FGF14-related ataxia patients and unaffected individuals. A total of 304 patients with late-onset ataxia and 190 unaffected individuals were previously screened for repeat expansions in FGF14 by long-range PCR, identifying 37 individuals with expanded repeat lengths (≥250 repeats). These, along with three newly identified expansion carriers were included in the present study, and advanced genetic methods were applied to investigate the repeat composition in 27 patients and 13 unaffected individuals. The expansions, based on Nanopore data, ranged from 236 to 486 repeats (standard deviation = 60), with 20 individuals showing repeat interruptions, including complex motifs such as GAG, GAAGGA, GAAGAAAGAA, GAAAAGAAGAAGGAAGAAGGAA, GAAAAGAAGAAGGAA and GCAGAAGAAGAAGAA. We calculated the longest pure GAA length from the long-read data for all 40 individuals. When comparing the pure GAA tract between patients and unaffected individuals, clusters were apparent based on >200 or <200 repeats. Five ataxia patients with interruptions still had a remaining pure GAA expansion <200. We observed an association of the pure GAA length with age at onset (P = 0.016, R2 = 0.256). Somatically incurred mosaic divergent repeat interruptions were discovered that affect motif length and sequence (mDRILS), which varied in number and mosaicism (frequency: 0.37–0.93). The mDRILS were correlated with pure GAA length (P = 0.022, R2 = 0.334), with a higher mosaic frequency of interruptions in unaffected individuals compared with patients (unaffected: 0.90; patients: 0.67; P = 0.009). We demonstrate that: (i) long-read sequencing is required to detect complex repeat interruptions accurately; (ii) repeat interruptions in FGF14 are mosaic, have various lengths and start positions in the repeat tract, and can thereby be annotated as mDRILS; which (iii) enabled us to establish a categorization based on remaining pure GAA repeats quantifying the impact of mDRILS on pathogenicity or age at onset, dependent on the interruption length and position, with high accuracy; and (iv) we provide evidence that mosaicism stabilizes pure GAA repeats in interrupted FGF14 repeat expansions.

25 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
CGCarolin Gabbert
Carolin Gabbert
LBLeonie Blöbaum
Leonie Blöbaum
TLTheresa Lüth
Theresa Lüth
IKInke R. König
Inke R. König
ACAmke Caliebe
Amke Caliebe
JTJoanne Trinh
Joanne Trinh
Objective: To investigate the association between a Parkinson’s disease (PD)-specific polygenic score (PGS) and protective lifestyle factors on age at onset (AAO) in PD. Methods: We included data from 4375 patients with idiopathic PD, 167 patients with GBA1 -PD, and 3091 healthy controls of European ancestry from AMP-PD, PPMI, and Fox Insight cohorts. The PGS was calculated based on a previously proposed composition of 1805 variants. The association between PGS and lifestyle factors (i.e., coffee, tobacco, and aspirin) on AAO was assessed with linear and Cox proportional hazards models. Results: The PGS showed a negative association with AAO (β=-1.07, p=6x10 -7 ). The use of one, two, or three of the protective lifestyle factors showed a reduction in the hazard ratio by 21% (p=0.0001), 45% (p<2x10 -16 ), and 55% (p0.05). Interpretation: In our cohort, coffee, tobacco, aspirin, and PGS are independent predictors of PD AAO. Additionally, lifestyle factors seem to have a greater influence on AAO than common genetic risk variants with aspirin presenting the largest effect. External validation of our findings is needed.

9 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
TLTheresa Lüth
Theresa Lüth
BLBjörn-Hergen Laabs
Björn-Hergen Laabs
SSSebastian Sendel
Sebastian Sendel
IKInke R. König
Inke R. König
ACAmke Caliebe
Amke Caliebe
G(Global Parkinson’s Genetics Program (GP2)
Global Parkinson’s Genetics Program (GP2)
Objectives: The LRRK2 p.Gly2019Ser pathogenic variant has reduced penetrance and presents a wide range of age at onset (AAO) in patients with Parkinson’s disease (PD). We aim to elucidate differences in the cumulative incidence of LRRK2 p.Gly2019Ser - related PD ( LRRK2 -PD) between ancestries and countries. Methods: We included N=922 unrelated LRRK2 p.Gly2019Ser variant carriers (affected: N=762, unaffected: N=160) from the Global Parkinson’s Genetics Program (GP2) in addition to cohorts recruited from the Israeli Ashkenazi Jewish and Tunisian Arab-Berber population. The p.Gly2019Ser variant was present in five ancestries: Ashkenazi Jewish (N=534), North African (N=223), European (N=132), Middle Eastern (N=19) and Latino and Indigenous people of the Americas (N=14). In addition to ancestry derived from the genetic data, we assessed the country of origin in our analysis. The Cox proportional-hazards model and Kaplan-Meier analysis were applied to examine differences in cumulative incidence. All analyses were adjusted for biological sex, and the outcome variable was AAO, including affected and unaffected variant carriers with right censoring for affection status, and all analysis were exploratory. Results: The median AAO of LRRK2 -PD was five years younger in the North African (HR=1.48, 95% CI: 1.18-1.86, p=7.0×10 −4 ) compared to the European ancestry group. In contrast, the median AAO was five years older in the Ashkenazi Jewish (HR=0.61, 95% CI: 0.50-0.75, p=4.0×10 −6 ) compared to the European ancestry group. Additionally, patients from Israel (HR=1.59, 95% CI: 1.30-1.39, p=4.0×10 −6 ) and Tunisia (HR=2.57, 95% CI: 2.16-3.06, p<2.0×10 −16 ) had a median 5-year and 10-year younger AAO compared to patients from the USA, respectively. Lastly, when focusing only on individuals with an Ashkenazi Jewish background, patients from Israel still had a younger AAO than those from the USA (HR=1.82, 95% CI: 1.48-2.24, p=1.5×10 −8 ). Analogously, assessing only patients from the USA, the Ashkenazi Jewish ancestry group still had an older AAO than the European ancestry group (HR=0.51, 95% CI: 0.39-0.67, p=1.3×10 −6 ). Discussion: Our results provide evidence that a person’s genetic ancestry and country of origin are associated with the AAO of LRRK2 -PD. This highlights the potential impact of both genetic and environmental factors on LRRK2 -PD AAO.

22 November 2024 in medRxiv
Verified
Preprint
Open access
PDF file
JLJoshua Laß
Joshua Laß
MTMirja Thomsen
Mirja Thomsen
MBMax Borsche
Max Borsche
TLTheresa Lüth
Theresa Lüth
JPJulia C. Prietzsche
Julia C. Prietzsche
JTJoanne Trinh
Joanne Trinh
Deep intronic FGF14 repeat expansions have been identified as a frequent genetic cause of late-onset cerebellar ataxias, explaining up to 30% of patients. Interruptions between repeats have previously been identified to impact the penetrance in other repeat expansion disorders. Repeat interruptions within FGF14 have yet to be characterized in detail. We utilized long-range PCR, Sanger sequencing, repeat-primed PCR, Nanopore, and PacBio sequencing to distinguish the repeat motifs, mosaicism, and number of repeat interruptions present in FGF14 -related ataxia patients and unaffected individuals. A total of 304 patients with late-onset ataxia and 190 unaffected individuals were previously screened for repeat expansions in the FGF14 gene by long-range PCR, identifying 37 individuals with expanded repeat lengths (≥250 repeats). These, along with three newly identified expansion carriers were included in the present study, and advanced genetic methods were applied to investigate the repeat composition in 27 patients and 13 unaffected individuals. The expansions, based on Nanopore data, ranged from 236 to 486 repeats (SD = 60), with 20 individuals showing repeat interruptions, including complex motifs such as GAG , GAA GGA , GAAGAA A GAA, GAAA A GAAGAA G GAAGAA G GAA, GAAA A GAAGAA G GAA, and GCA GAAGAAGAAGAA. We calculated the longest pure GAA length from the long-read data for all 40 individuals. When comparing the pure GAA tract between patients and unaffected individuals, clusters were apparent based on greater or less than 200 repeats. Five ataxia patients with interruptions still had a remaining pure GAA expansion >200. We observed an association of the pure GAA length with age at onset ( p =0.016, R 2 =0.256). Somatically-incurred mosaic divergent repeat interruptions were discovered that affect motif length and sequence (mDRILS), which varied in number and mosaicism (frequency: 0.37-0.93). The mDRILS correlated with pure GAA length ( p =0.022, R 2 =0.334), with a higher mosaic frequency of interruptions in unaffected individuals compared to patients (unaffected: 0.90; patients: 0.67; p =0.009). We demonstrate that i) long-read sequencing is required to detect complex repeat interruptions accurately; ii) repeat interruptions in FGF14 are mosaic, have various lengths and start positions in the repeat tract, and can thereby be annotated as mDRILS, which iii) enabled us to establish a categorization based on remaining pure GAA repeats quantifying the impact of mDRILS on pathogenicity or age at onset, dependent on the interruption length and position, with high accuracy. Finally, we iv) provide evidence that mosaicism stabilizes pure GAA repeats in interrupted FGF14 repeat expansions.